investors.aeriepharma.comInvestor Relations | Aerie Pharmaceuticals, Inc
investors.aeriepharma.com Profile
investors.aeriepharma.com
Maindomain:aeriepharma.com
Title:Investor Relations | Aerie Pharmaceuticals, Inc
Description：The Investor Relations website contains information about Aerie Pharmaceuticals business for stockholders, potential investors, and financial analysts.
Discover investors.aeriepharma.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
investors.aeriepharma.com Information
| Website / Domain: | investors.aeriepharma.com |
| HomePage size: | 33.448 KB |
| Page Load Time: | 0.726919 Seconds |
| Website IP Address: | 184.50.88.72 |
| Isp Server: | Akamai Technologies Inc. |
investors.aeriepharma.com Ip Information
| Ip Country: | United States |
| City Name: | San Jose |
| Latitude: | 37.339389801025 |
| Longitude: | -121.89495849609 |
investors.aeriepharma.com Keywords accounting
| Keyword | Count |
|---|
investors.aeriepharma.com Httpheader
| Accept-Ranges: bytes |
| Content-Encoding: gzip |
| Content-Language: en |
| Content-Security-Policy: report-uri //report-csp-violation |
| Content-Type: text/html; charset=UTF-8 |
| device: desktop |
| ETag: "1580679086" |
| From-Origin: same |
| Last-Modified: Sun, 02 Feb 2020 21:31:26 GMT |
| Link: http://investors.aeriepharma.com/; rel="shortlink", http://investors.aeriepharma.com/; rel="canonical", https://investors.aeriepharma.com/investor-relations; rel="alternate"; hreflang="en", https://investors.aeriepharma.com/investor-relations; rel="revision" |
| Server: nginx |
| X-Age: 0 |
| X-Content-Security-Policy: report-uri //report-csp-violation |
| X-Content-Type-Options: nosniff |
| X-Drupal-Dynamic-Cache: UNCACHEABLE |
| X-Frame-Options: SAMEORIGIN |
| X-Generator: Drupal 8 (https://www.drupal.org) |
| X-Request-ID: v-5dc428d0-4603-11ea-8b6e-e3cf09fcedc0 |
| X-UA-Compatible: IE=edge |
| X-WebKit-CSP: report-uri //report-csp-violation |
| X-XSS-Protection: 1; mode=block |
| Content-Length: 8927 |
| X-EdgeConnect-MidMile-RTT: 43, 43 |
| X-EdgeConnect-Origin-MEX-Latency: 388, 388 |
| Cache-Control: public, max-age=0, s-maxage=1800 |
| Expires: Sun, 02 Feb 2020 21:31:26 GMT |
| Date: Sun, 02 Feb 2020 21:31:26 GMT |
| Connection: keep-alive |
| Vary: Accept-Encoding |
| Set-Cookie: SimpleSAMLSessionID=e434a1c255be0c9e430a88c8b2e221bd; path=/; secure; HttpOnly, DrupalVisitorMobile=0; path=/ |
| Strict-Transport-Security: max-age=15768000 ; preload |
investors.aeriepharma.com Meta Info
| charset="utf-8"/ |
| content="Investor Relations | Aerie Pharmaceuticals, Inc" name="title"/ |
| content="Aerie Pharmaceuticals, Inc" property="og:site_name"/ |
| content="website" property="og:type"/ |
| content="The Investor Relations website contains information about Aerie Pharmaceuticals business for stockholders, potential investors, and financial analysts." name="description"/ |
| content="no-referrer" name="referrer"/ |
| content="Drupal 8 (https://www.drupal.org)" name="Generator"/ |
| content="width" name="MobileOptimized"/ |
| content="true" name="HandheldFriendly"/ |
| content="width=device-width, initial-scale=1.0" name="viewport"/ |
184.50.88.72 Domains
| Domain | WebSite Title |
|---|
investors.aeriepharma.com Similar Website
| Domain | WebSite Title |
|---|---|
| Investor Relations | Regeneron Pharmaceuticals Inc. | |
| Investor Relations | Regeneron Pharmaceuticals Inc. | |
| Amneal Pharmaceuticals Inc - Investor Relations | |
| Investor Relations | Enzon Pharmaceuticals | |
| Investor Relations | Alexion Pharmaceuticals, Inc. | |
| Investor Relations | Vertex Pharmaceuticals | |
| Eagle Pharmaceuticals Investor Center | | |
| Investor Relations | Progenics Pharmaceuticals, Inc. | |
| Investor Relations - Supernus Pharmaceuticals | |
| Investor Relations - Spectrum Pharmaceuticals, Inc. | |
| Investor Relations | Aerie Pharmaceuticals, Inc | |
| Investor Relations :: Titan Pharmaceuticals, Inc. (TTNP) | |
| Investor Summary :: Ligand Pharmaceuticals Incorporated (LGND) | |
| ZUCHE PHARMACEUTICALS PRIVATE LIMITED - Pharmaceuticals,Medical Devices | |
| Aerie Pharmaceuticals | Leading Ophthalmic Pharmaceuticals |
investors.aeriepharma.com Traffic Sources Chart
investors.aeriepharma.com Alexa Rank History Chart
investors.aeriepharma.com Html To Plain Text
Skip to main navigation Top Nav Contact SEARCH About Us Our Scientific Heritage Aerie At-a-Glance Our Leadership Our Board of Directors Our ESG Commitment Products Rhopressa ® Rocklatan ™ R&D Pipeline AR-13503 Implant AR-1105 Implant Drug Delivery Clinical Trials Research Bibliography Investigator Initiated Research For Eye Care Professionals Our VISION aerie ™ Legacy Aqueous Humor Dynamics Trabecular Meshwork ROCK Inhibition Medical Affairs Investors FAQs News & Presentations News Releases Events & Presentations Stock Information Historic Stock Lookup Investment Calculator Dividend History Reports & Filings SEC Filings Annual Reports & Proxies Quarterly Results Corporate Governance Compliance Committee Composition Contact the Board Our ESG Commitment Our Leadership Our Board of Directors Contact Us Sign up for email alerts Careers Working at Aerie Investors Investor Relations FAQs News & Presentations News Releases Events & Presentations Stock Information Historic Stock Lookup Investment Calculator Dividend History Reports & Filings SEC Filings Annual Reports & Proxies Quarterly Results Corporate Governance Compliance Committee Composition Contact the Board Our ESG Commitment Our Leadership Our Board of Directors Contact Us Sign up for email alerts Investor Relations We began with a vision, and now we’ve grown into an ophthalmic pharmaceutical company focused on discovering, developing and commercializing first-in-class therapies for treating open-angle glaucoma and other diseases of the eye. Leadership Team Meet the eye care VISION aerie S™ building the next major ophthalmic pharmaceutical company. MORE Stock Information Feb 2, 2020 4:31 PM EST MORE REPORTS AND FILINGS Review the latest annual report, quarterly reports, and other SEC filings. MORE © Aerie Pharmaceuticals, Inc . All Rights Reserved. This site intended for U.S. audiences. Footer Terms of Use Privacy Policy Site Map...
investors.aeriepharma.com Whois
"domain_name": "AERIEPHARMA.COM",
"registrar": "Network Solutions, LLC",
"whois_server": "whois.networksolutions.com",
"referral_url": null,
"updated_date": [
"2020-02-02 09:11:43",
"2020-02-02 09:17:43"
],
"creation_date": "2005-04-02 05:13:53",
"expiration_date": "2021-04-02 04:13:53",
"name_servers": [
"NS15.WORLDNIC.COM",
"NS16.WORLDNIC.COM"
],
"status": "clientTransferProhibited https://icann.org/epp#clientTransferProhibited",
"emails": [
"abuse@web.com",
"hb8kc6mn9e5@networksolutionsprivateregistration.com"
],
"dnssec": "unsigned",
"name": "PERFECT PRIVACY, LLC",
"org": null,
"address": "5335 Gate Parkway care of Network Solutions PO Box 459",
"city": "Jacksonville",
"state": "FL",
"zipcode": "32256",
"country": "US"